Form 4 for ANIX Anixa Biosciences Inc
Accepted 2026-07-29 09:14:58 ET · period of report 2026-07-27 · accession 0001493152-26-035122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-29 09:14 | 2026-07-27 | ANIX | Baskies Arnold M | Dir | M - OptEx | $3.13 | +6,000 | 141.0K | +4% | +$18.8K |
| D | 2026-07-29 09:14 | 2026-07-27 | ANIX | Baskies Arnold M | Dir | F - Tax | $3.46 | -5,428 | 135.6K | -4% | -$18.8K |
| D | 2026-07-29 09:14 | 2026-07-27 | ANIX | Baskies Arnold M | Dir | M - OptEx | $0.00 | -6,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-27 | M | A | 6,000 | $3.13 | 141,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-27 | F | D | 5,428 | $3.46 | 135,572 | D | — | — | (F1) The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-07-27 | M | D | 6,000 | $0.00 | 0 | D | $3.13 · 2016-08-23 to 2026-08-23 | 6,000 Common Stock | (F2) Right-To-Buy, pursuant to a stock option grant dated August 23, 2013. |